Skip to content Skip to navigation

Proteomics of ADNIV

We are using proteomics to study the vitreous fluid from eyes with ADNIV.

News

Dec 21 2017 | Stanford Report | Posted In: 20/20 Blog, Press
Researchers are studying proteins in the eye to find existing drugs that can treat a rare eye disease known as neovascular inflammatory vitreoretinopathy that causes blindness.   Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of...

Publications

Therapeutic drug repositioning using personalized proteomics of liquid biopsies, Velez, Gabriel, Bassuk Alexander G., Colgan Diana, Tsang Stephen H., and Mahajan Vinit B. , JCI insight, Volume 2, (2017)